Virginia Genovesi
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Reply to: "Establish a streamlined molecular profiling workflow for the clinical management of advanced cholangiocarcinoma".
Journal: Journal of hepatology
Published: May 05, 2026
Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort.
Journal: ESMO open
Published: October 31, 2025
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab.
Journal: Targeted oncology
Published: September 18, 2025
FOLFOX Versus FOLFIRI as Second-Line Chemotherapy in Patients With Advanced Biliary Tract Cancers: A Multicenter, Italian Study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 14, 2025
Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy.
Journal: Oncology
Published: March 25, 2025
Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study.
Journal: ESMO gastrointestinal oncology
Published: August 19, 2024
Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Carcinomatosis: The Need for Clear Answers Through Proper Questions.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 14, 2024
Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 24, 2024
Abdominal Visceral-to-Subcutaneous Fat Volume Ratio Predicts Survival and Response to First-Line Palliative Chemotherapy in Patients with Advanced Gastric Cancer.
Journal: Cancers
Published: September 27, 2023
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 09, 2023
Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade.
Journal: Journal for immunotherapy of cancer
Published: May 16, 2023
Last Updated: 09/26/2026